3 completed, 2 recruiting, 2 unknown. 7 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 3, Recruiting 2, Unknown 2 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow THC: new trials by email Literature Review of THC trials Research Report on THC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Behavioral Pharmacology of Orally Administered THC and D-limonene D-Limonene, Delta-9-THC, Placebo - Subjective Drug Effects, THC | Phase 1 | Recruiting | Johns Hopkins University | 65 | 2025-02-14 | 2026-05-28 |
| Modulation of THC Effects by CBD: a Dose-ranging Study ∆9-tetrahydrocannabinol - Cannabis, THC | Phase 1 / Phase 2 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 100 | 2024-06-27 | 2025-12-22 |
| THC Memory & Reward Learning Pilot Marijuana, Hash, THC, or Grass, Placebo - Marijuana, THC | Phase 1 / Phase 2 | Unknown | Hartford Hospital | 20 | 2022-07-07 | 2025-03-17 |
| A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults CBD and THC with GT4 technology - Biological Availability, Skin Absorption | Phase 1 | Completed | Gefion Canada Inc. | 18 | 2021-11-27 | 2022-06-01 |
| A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Cybis™ 10:25 THC:CBD oil - Chronic Pain, Neck Pain | Phase 1 / Phase 2 | Completed | Cymra Life Sciences | 28 | 2021-09-20 | 2022-07-07 |
| Behavioral Pharmacology of THC and Alpha-pinene Placebo, THC, Alpha-Pinene - THC, Alpha-pinene | Phase 1 | Completed | Johns Hopkins University | 33 | 2020-11-05 | 2025-05-22 |
| A Bioavailability Study on Dronabinol Chewing Gum - THC | Phase 1 | Unknown | Axim Biotechnologies | 50 | 2018-01-01 | 2017-04-04 |
Marijuana Abuse (2) · Back Pain (1) · Chronic Pain (1) · Neck Pain (1) · Pain (1)
Chemically-Induced Disorders (2) · Mental Disorders (2) · Substance-Related Disorders (2) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Dronabinol (4) · nabiximols (2) · Cannabidiol (1) · Chewing Gum (1) · Limonene (1) · alpha-pinene (1)
Johns Hopkins University (2) · Axim Biotechnologies (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Cymra Life Sciences (1) · Gefion Canada Inc. (1) · Hartford Hospital (1)
United States (3) · Canada (2) · Australia (1)
Austin Zamarripa, PhD (1) · David Crowley, MD (1) · Didier Jutras-Aswad, MD, MS (1) · Godfrey Pearlson, M.D (1) · Richard Chye (1) · Ryan Vandrey, PhD (1)
R01DA043475 (1)